What's in Store for West Pharmaceutical in Q3 Earnings? [Yahoo! Finance]
West Pharmaceutical Services, Inc. (WST)
Last west pharmaceutical services, inc. earnings: 4/23 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investor.westpharma.com
Company Research
Source: Yahoo! Finance
In the last reported quarter, the company delivered an earnings miss of 14.12%. WST's earnings beat estimates in three of the trailing four quarters and missed once, delivering an average surprise of 6.44%. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. Q3 Estimates Currently, the Zacks Consensus Estimate for revenues is pegged at $710.2 million, indicating a decline of 5% from the year-ago period's level. The consensus mark for earnings is pinned at $1.51 per share, indicating a decline of 30.1% year over year. Factors to Note During the second quarter, West Pharmaceutical's Proprietary Products segment sales were hurt by an elevated level of customer destocking across its business units. The trend is likely to have continued in the third quarter, pulling sales down. A weak pharma market and declining sales related to COVID-19 vaccines are expected to have contributed to the decline. The declining trend in the Generic market unit and the Biologics
Show less
Read more
Impact Snapshot
Event Time:
WST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WST alerts
High impacting West Pharmaceutical Services, Inc. news events
Weekly update
A roundup of the hottest topics
WST
News
- Reasons to Hold West Pharmaceutical Stock in Your Portfolio Now [Yahoo! Finance]Yahoo! Finance
- West Pharmaceutical Services, Inc. (NYSE: WST) had its price target raised by analysts at Bank of America Co. from $350.00 to $355.00. They now have a "buy" rating on the stock.MarketBeat
- West Pharmaceutical Services, Inc. (NYSE: WST) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.MarketBeat
- West Pharmaceutical Services, Inc. (NYSE: WST) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $390.00 price target on the stock, up previously from $350.00.MarketBeat
- West Elects New Director to the BoardPR Newswire
WST
Earnings
- 10/24/24 - Beat
WST
Sec Filings
- 12/18/24 - Form 3
- 12/18/24 - Form 4
- 12/13/24 - Form 8-K
- WST's page on the SEC website